Introduction
Malnutrition is a cardinal clinical manifestation of acquired immunode®ciency syndrome (AIDS), but even early, asymptomatic human immunode®ciency virus type-1 (HIV) infection may lead to impaired nutritional status. However, impaired nutritional status is not only a characteristic of HIV/AIDS in parallel to immunode®ciency. Micronutrient de®ciencies may impair host immunefunctions and affect viral replication and pathogenicity, thus potentially affecting transmission and clinical course of infection. Therefore, improved nutrition may play a role in sexual and mother-to-child HIV transmission, progression of HIV to AIDS, as well as mortality from AIDS.
Although dietary counselling or provision of an optimal diet is important in the case management of HIV patients, this is generally not an option in developing countries harbouring the vast majority of the worlds HIV infected individuals. In developing countries, however, micronutrient supplementation via the primary health care system to high-risk populations may be an operationally feasible and affordable public health measure. This paper reviews the literature on micronutrients and HIV infection, and discuss the potential role of increased micronutrient intake as a measure to reduce HIV transmission and progression.
Effects of infection on micronutrient level

Infections in general
Infections may reduce the intake and absorption, as well as increase utilisation and excretion of micronutrients, thus impairing host micronutrient status. These effects are mediated by the acute phase response to infection, but effects of localized or organ-speci®c manifestations may be superimposed.
Acute and even chronic generalised infections give rise to an acute-phase response, that is a generalised, stereotypic host reaction caused by a cascade of cytokines released by activated phagocytic cells (Dinarello, 1984) . While the acute-phase response serves to enable the host to withstand invading pathogens and repair tissue damage, it also compromises host nutritional status (Beisel, 1992) . Anorexia and fever are prominent constitutional signs of the acutephase response. Anorexia leads to reduced intake of food and, hence, micronutrients. Fever is accompanied by catabolism of muscle tissue with mobilisation of amino acids needed for proliferation of neutrophils, lymphocytes, and ®broblasts, and for synthesis of immunogloblins and hepatic acute phase proteins. Concurrently, the serum concentrations of iron and zinc fall dramatically due to redistribution within the body, with accumulation in the liver. This serves to make iron and zinc available to organs and cells with increased requirements, but is also thought to be purposeful in making these minerals unavailable to invading micro-organisms (Keusch & Farthing, 1986) . The serum concentration of retinol (vitamin A) also falls, since it is bound to the negative acute phase proteins retinol binding protein (RBP) and transthyretin, which¯ux to the extravascular space during infections (Thurnham, 1989) . While the decline in serum retinol seems to be partly transient, it is followed by an increased utilisation of retinol in the tissues (Thurnham & Singkamani, 1991) , as well as increased renal excretion (Stephensen et al, 1994) .
Therefore, while infections reduce micronutrient status per se, it may also independently affect serum levels of the quantities used to assess status (Filteau & Tomkins, 1994) , and give raise to misclassi®cation of micronutrient status (Brown et al, 1993) . Thus, it is necessary to distinguish between micronutrient status and level.
Infections are also characterised by release of reactive oxygen species and pro-oxidant cytokines from activated phagocytes (Schwarz, 1996) . This leads to increased consumption of vitamins serving as antioxidants (for example, vitamin E and C, and b-carotene) and sequestration of minerals serving as components of antioxidant enzymes (for example zinc, copper, manganese, selenium) (Bendich, 1990; Delmas Beauvieux et al, 1995) .
HIV infection
Up to 50±90% develop symptomatic primary HIV infection a couple of weeks after being infected with HIV (Tindall & Cooper, 1991) . In addition to the metabolic effects of this febrile illness, some speci®c signs and symptoms of primary HIV infection may contribute to the impairment of nutritional status. The reduced intake due to anorexia may be exacerbated by nausea, vomiting, sore throat, buccal and oesophageal ulcers or candidiasis, and accompanied by diarrhoea and malabsorption, caused by the reduction in the number of CD4 T-cells (the key immune parameter in HIV/ AIDS), during primary HIV infection (Tindall & Cooper, 1991) .
Even during the long period of asymptomatic HIV infection following primary infection, intensive viral replication takes place in lymphoid tissue (Pantaleo et al, 1993) . Since the gastrointestinal tract is the largest lymphoid organ in the body it is obviously important in HIV infection, and several studies have identi®ed HIV in the intestinal tract in intraepithelial lymphocytes and in mononuclear cells in the lamina propria as reviewed by Smith et al (1992) . Since small intestinal villous atrophy, crypt hyperplasia and malabsorption have been reported in HIV infected individuals without identi®able enteric pathogens, the existence of an enteropathy due to HIV per se has been suggested (Ullrich et al, 1989) . Alternatively, diarrhoea and malabsorption could result from bacterial overgrowth due to secondary mucosal immune system impairment (Smith et al, 1992) and facilitated by acid secretory failure (Lake Bakaar et al, 1996) .
With development of advanced HIV disease, fever, opportunistic infections or malignancies cause reduced food intake due to reduced appetite or taste disturbances, or painful mucosal lesion of the mouth, pharynx or oesophagus. Likewise, 30±50% of patients in developed and nearly 90% in developing countries develop diarrhoea and, hence, malabsorption (Smith et al, 1992) .
Although the effects of HIV infection on the micronutrient status are likely to be more important among underprivileged populations with low micronutrient intake, few data have been reported from developing countries Phuapradit et al, 1996) . In contrast, a large number of studies even in populations in af¯uent countries document that HIV infected individuals, despite high dietary and supplemental intakes of micronutrients, often have low serum concentrations of vitamins A, B 6 , B 12 , C, E, and folate and carotenoids, as well as selenium, zinc and magnesium (Bogden et al, 1990; Beach et al, 1992; Coodley et al, 1993; Baum et al, 1994; Sappey et al, 1994; Delmas Beauvieux et al, 1996; Lacey et al, 1996; Skurnick et al, 1996) . Although the metabolic response to infection may contribute to the low serum concentrations for some micronutrients, there is no doubt that the`intake of nutrients at levels recommended for the general population does not appear to be adequate for HIV-1 infected patients' as concluded by Baum et al (1995) . Thus, the importance of any possible effects of micronutrient de®-ciencies on HIV progression and transmission is evident.
Effects of micronutrients on HIV infection
A large number of micronutrients are essential for speci®c and non-speci®c immunefunctions as reviewed by Beisel (1982) . The acronym NAIDSÐNutritionally Acquired Immune De®ciency Syndrome, has been used for these effects of malnutrition which is probably the most prevalent immunosuppressive disorder globally (Beisel, 1996) . In addition to direct effects on immunefunctions, de®ciencies of antioxidants cause increased oxidative stress which lead to apotopsis of T-cells and indirectly compromise cellmediated immunity (Baruchel & Wainberg, 1992) .
The importance of nutrition in AIDS was recognised early in the epidemic, and it was suggested that AIDS was an opportunistic infection with a retrovirus due to a nutritional de®ciency compromising the immune system (Jain & Chandra, 1984) . While this has proved not to be the case, evidence suggesting that nutritional de®ciencies may be important cofactors in HIV disease is now accumulating, and the need for clinical trials on the effect of nutritional interventions has been recommended (Timbo & Tollefson, 1994) . Micronutrient de®ciencies, either existing prior to HIV infection, precipitated by symptomatic primary infection or caused by established HIV infection, may affect transmission as well as clinical course of HIV infection. These effects may be mediated through effects on immunefunctions, as well as on viral replication and pathogenicity.
Micronutrient de®ciencies may affect replication of the invading virus. Adverse effects of micronutrient de®cien-cies and, hence, bene®cial effects of increased dietary and supplemental intake of physiological doses are most conceivable. But, in analogy with other infections, speci®c micronutrient de®ciencies may also favour the host, and supplementation favour the virus. For example, HIV replication was enhanced in monocytes cultured with retinoid (Turpin et al, 1992) , whereas addition of retinoid to previously infected monocytes blocked the induction of HIV expression (Poli et al, 1992) . Similarly, HIV nucleocapsid protein binds zinc and forms zinc ®nger structures, and compounds attacking these zinc ®ngers have recently been shown to inactivate cell-free virus, inhibit acute and chronic infections, and exhibit broad antiretroviral activity (Rice et al, 1995) . Thus, it is conceivable though not con®rmed that a high zinc intake increases the replication of HIV. As for other infections, the role of iron in HIV infection may be complex, since iron is important for optimal immune function, but is also a pro-oxidant and may as such promote replication, as has been shown in laboratory studies (Sappey et al, 1995) . This may be important, since high body iron stores is a common feature in advanced HIV disease (Boelaert et al, 1996) , but studies on its impact on progression or transmission are lacking.
In cell cultures, HIV replication has been shown to be stimulated by reactive oxygen species via activation of the nuclear transcription factor cell gene, and inhibited by various antioxidants (Kalebic et al, 1991) . Thus, it is likely that if the increased requirements for antioxidant micronutrients during HIV infection are not met, then oxidative stress may stimulate HIV replication (Baruchel & Wainberg, 1992) . Accordingly, a recent randomised, controlled trial among 40 HIV infected individuals showed that a daily supplement of 800 IU vitamin E and 1000 mg of vitamin C over three months reduced oxidative stress, and was associated with a marginally signi®cant reduction in viral load compared to placebo (70.5 vs 0.5 log 10 , P 0.1) (Allard et al, 1997) . Nevertheless, since the infection-induced oxidative burst is important for the bactericidal properties of phagocytes, concern has been expressed that high intake of antioxidants may promote opportunistic infections (Schwarz, 1996) . Therefore, and since the effects may be of potential importance at least among HIV infected individuals with no access to antiretroviral drugs, randomised, controlled clinical trials on the effects of physiologic doses of antioxidants on viral load as well as on clinical outcomes are warranted.
Micronutrient de®ciencies may also increase the pathogenicity of an infectious agent, as recently exempli®ed by a study of Coxackievirus infection in mice (Beck et al, 1995) , where a benign Coxackievirus mutated to a virulent phenotype after passage through selenium de®cient mice. The possible mutagenic effects of host de®ciencies of selenium or other micronutrients on HIV have apparently not been studied.
The results of human, longitudinal studies assessing the relationship between micronutrient intake or level among HIV infected individuals on progression and transmission of HIV are reviewed below.
Progression of HIV
The time from HIV infection to AIDS as well as from AIDS to death is of highly variable length. Even in af¯uent countries, the time from infection is variable with 20% progressing to AIDS within ®ve years, while 12% remain free of AIDS for 20 years (Mellors et al, 1996) . This suggests the existence of potent cofactors. Although virological and genetic factors may be involved, there are data indicating that micronutrient intake and level are associated with progression of HIV infection to AIDS or death.
Micronutrient intake. Tang examined the relationship between dietary and supplemental intake of micronutrients, and progression (Tang et al, 1993) and mortality (Tang et al, 1996) in a cohort of 281 HIV infected homosexual men from the Multicenter AIDS Cohort Study (MACS), USA. The participants were followed for eight years, and age, symptoms, CD4 count and other potential confounding factors were controlled for using Cox proportional hazards models. The relationship between vitamin A and progression was U-shaped with an intake between two to four times the recommended dietary allowance (RDA) being associated with reduced progression. High intake of niacin was associated with reduced progression of HIV to AIDS. The relationship between high intake of vitamin C and reduced progression was marginally signi®cant. In contrast, intake of zinc only 30% above RDA, was associated with increased progression (Tang et al, 1993) . High intakes of B 1 , B 2 , B 6 and niacin were associated with improved survival (Tang et al, 1996) . In accordance with the effects on progression, a high zinc intake was associated with reduced survival, whereas the relationship between vitamin A and b-carotene intake, and survival were U-shaped. The study population had high intakes of micronutrients, and as noted by the authors, the study does not permit inferences about effects of micronutrient de®ciencies.
In a similar study, the relationship between dietary and supplemental micronutrient intake among 296 HIV infected homosexual men in the USA, and progression to AIDS during six years follow-up was assessed (Abrams et al, 1993) . When controlling for HIV disease stage at baseline using a composite measure of HIV symptoms and CD4 count, then high intakes of iron, vitamin E, ribo¯avin were signi®cantly associated with reduced progression, while vitamin A and C, and thiamine were marginally signi®cant. Furthermore, daily use of multi-micronutrients were associated with reduced progression. The authors take up an important discussion about whether or not CD4 count should be controlled for. If the effect on progression is mediated by CD4, then CD4 count should not be controlled for as it will attenuate any true association. If the effect is mediated through other mechanisms, then CD4 should be controlled for (Abrams et al, 1993) . Nonetheless, there are no doubts that the confounding effect of baseline differences in HIV disease stage should be controlled for in the design or analyses.
No studies on dietary or supplemental micronutrient intake on progression of HIV have been reported from developing countries. However, a randomised, controlled vitamin A supplementation trial was conducted among 118 full-term infants of HIV infected mothers (Coutsoudis et al, 1995) . Vitamin A reduced the incidence of overall morbidity among all children. Furthermore, vitamin A reduced the incidence of diarrhoea in the 19 children known to be HIV infected, but not in the 57 children known to be uninfected.
Micronutrient level. Among 179 intravenous drug users (IVDU) in USA, Semba et al (1993) found that low serum retinol (`1.05 mmol/L) was associated with a four-fold increase in mortality during two years of follow-up, when CD4 counts were controlled for. This ®nding was later con®rmed based on the results of a nested case-control study where 50 HIV infected IVDU dying of AIDS during two years follow-up were compared with 235 surviving. Low serum retinol, wasting and low CD4 counts were found to be independent risk factors of mortality , with an odds ratio for low serum retinol of 4.6. However, there was no relationship between serum retinol and viral load in plasma among IVDU (Semba et al, 1997a) .
The role of serum concentrations of vitamin A and E, on progression to AIDS and mortality was studied (Tang et al, 1997a) in the MACS cohort. High serum vitamin E was associated with reduced risk of progression to AIDS. Serum retinol was not a predictor, but this may be explained by the satisfactory vitamin A status of the study population. In another study, Tang examined associations between serum concentrations of B 6 , B 12 and folate and progression of HIV during nine year follow-up among a cohort of 310 HIV infected bi-and homosexual men in USA (Tang et al, 1997b) . Using time to ®rst AIDS diagnosis and decline in CD4 cells to below 200/mm 3 as outcome parameters, low serum B 12 was associated with a median AIDS-free survival period of four years, compared to eight years among individuals with normal serum B 12 . The effect persisted when CD4 count and other potential confounding factors were controlled for in the analyses, whereas neither serum B 6 nor folate were signi®cant.
Based on a cohort of 108 HIV infected homosexual men in the US, Baum studied the relationship between serum concentrations of various micronutrients, and changes in these concentrations over an 18-month period, and markers of disease progression (Baum et al, 1995) . Low serum B 12 was a predictor of progression, and those who developed low serum concentrations of retinol, B 12 and zinc had signi®cant decreases in CD4, whereas those who developed normal serum retinol, B 12 and zinc had an increase in CD4 (Baum et al, 1995) .
Recently, the relation between serum concentrations of vitamin A, E, B 6 and B 12 , and zinc and selenium and progression of HIV to mortality over 3.5 years follow-up was assessed in a cohort of 125 HIV infected IVDU (Baum et al, 1997) . Low concentrations of vitamin A, vitamin B 12 , zinc and selenium, but not vitamin B 6 and E, were signi®cant predictors of mortality when assessed individually while controlling for CD4 counts. However, assessed simultaneously in a multivariate model while controlling for CD4 counts, then low selenium was the only predictor of mortality, with a relative risk of 10. Similar strong effects of low selenium on mortality has recently been found from a cohort of HIV infected children as well as from a cohort of homosexual men (Marianna Baum, personal communication). If the relationship between low serum selenium and mortality is causal, then it may be mediated by impairment of immunefunctions, increased viral replication or even increased viral pathogenicity. The latter possibility is indeed interesting in view of the recent study of mutagenic effects of selenium de®ciency on Coxackievirus in mice (Beck et al, 1995) .
In a study from Malawi, serum retinol among pregnant HIV infected women was found to be inversely related to maternal mortality (Semba, 1997b) , but also to mortality among their infants before 12-month, before their HIV status could be assessed serologically . In fact, mortality fell from 93% in infants of women with serum retinol below 0.35 mmol/L to 14.2% in infants of vitamin A replete women. It should be noted, that although data from the same study identi®ed low serum retinol as a risk factor for mother-to-child HIV transmission among infants surviving 12 months (see below), a proportion of these infant deaths may be attributable to infections other than HIV. This is conceivable, since new-born infants have small hepatic vitamin A stores, and depend on a high vitamin A content in breast milk. As HIV infection per se contribute to vitamin A depletion of the mother, new-born HIV-infected or -uninfected infants born to HIV infected women often have low serum vitamin A (Cunningham Rundles et al, 1996) , and fail to become repleted through breast feeding. Similarly, low maternal serum retinol in pregnancy was a signi®cant predictor of perinatal and infant mortality in a study from Rwanda (Dushimimana et al, 1992) .
Transmission of HIV
Sexual transmission. Although a complex of cultural, socio-economic, behavioural and biological factors determines sexual transmission, micronutrient de®ciencies may theoretically affect infectivity of HIV infected individuals as well as susceptibility of exposed uninfected individuals.
Firstly, micronutrient de®ciencies contributing to impaired speci®c and non-speci®c immunefunctions or allowing oxidative stress to stimulate viral replication, may increase viral load of blood and body¯uids, such as seminal¯uid and cervico-vaginal secretions, and thus increase infectivity. Semba did not demonstrate any relationship between serum retinol (Semba et al, 1997a ) and viral load in plasma among IVDU in the USA. In South Africa, combined vitamin A and b-carotene supplementation in 12 pregnant women did not signi®cantly affect changes in viral load compared to placebo, albeit viral load after supplementation was signi®cantly lower (Coutsoudis et al, 1997). A recent study from Kenya among HIV infected women showed that the risk of vaginal shedding of HIV DNA increased considerably with serum retinol declining below 1.40 mmol/L (Mostad et al, 1997) .
Secondly, it is likely that HIV infected individuals with de®ciencies of micronutrients of importance for speci®c as well as non-speci®c immunefunctions are more susceptible to infection with HIV, or to genital infections which are known risk factors for HIV (Grosskurth et al, 1995) . Vitamin A de®ciency in particular is a conceivable risk factor for HIV infection, since it impairs epithelial integrity , which is the ®rst line of defence against HIV. However, this could not be con®rmed in a nested case-control study in Rwanda (Moore et al, 1993) , where only weight loss, but neither serum concentrations of retinol, carotenoids, vitamin E, selenium or ferritin, were found to be signi®cant predictors of later seroconversion. Exposure to HIV, however, is obviously an important confounding factor not easily controlled for in observational studies.
While both of these potential effects are obviously most important in poor populations with low dietary intake and nutritional status, the effect on infectivity may also be of importance in af¯uent populations since even early HIV infection impairs micronutrient status.
Mother-to-child transmission. Mother-to-child HIV transmission represents a special case where an uninfected individual, the foetus or infant, is exposed to HIV in body¯uids of an infected mother. While transmission may take place in utero, it usually occurs as the child passes through the birth canal or (in a breast feeding population) through breast milk. The rates of mother-tochild HIV transmission reported from developing countries are in the range 25±30%, while it ranged from 14±25% in developed countries (Working Group on Mother-ToChild Transmission of HIV, 1995) prior to the routine use of antiretrovirals. A proportion of this difference is attributable to breast feeding, but micronutrient de®ciencies among women in developing countries, exacerbated by the higher requirements during pregnancy and lactation, may play a role. Maternal micronutrient de®ciencies may increase viral load in the body¯uids, for example blood, cervico-vaginal secretions and breast milk, and hence in utero, intrapartum and post-natal mother-to-child HIV transmission, respectively. This effect could be directly mediated by oxidative stress or impairment of immunefunctions, or indirectly by increasing the risks of genital infections known to be associated with HIV shedding in cervico-vaginal secretions (Mostad et al, 1997) . Additionally, maternal micronutrient de®ciencies may reduce the micronutrient status of the foetus or infant, thereby affecting immune functions and susceptibility of the unborn or young breast fed child.
Recent data from observational studies support the potential role of micronutrient de®ciencies as a risk factor for mother-to-child HIV transmission. A study from Kenya showed that low serum retinol (`70 mmol/L) among lactating HIV infected women with low CD4 counts (`400 mm 3 ) was strongly associated with the presence of HIV DNA in breast milk (Nduati et al, 1995) . Similarly, another study from Kenya showed that low serum retinol was a risk factor for identifying HIV DNA in samples of vaginal, but not cervical, secretions among third term pregnant women when controlled for CD4 and vaginal discharge (John et al, 1997) . These two studies suggest that maternal vitamin A de®ciency could lead to an increased exposure of the child for HIV as it passes through the birth canal and during breast feeding. These ®ndings are in agreement with those from Malawi of an inverse relationship between maternal serum retinol in pregnancy and risk of mother-to-child HIV transmission . Women with serum retinol concentration below 0.70 mmol/L at the ®rst visit to the antenatal clinic had a four-fold increased risk of having an HIV infected child at the age of one year compared to women with serum retinol above 1.40 mmol/L.
Interestingly, among HIV infected third trimester pregnant women for the USA, low serum retinol (`0.70 mmol/ L) was a predictor of mother-to-child HIV transmission in one study (Greenberg et al, 1997) , whereas neither serum concentrations of retinol, tocopherol, b-carotene nor lucopene were associated with mother-to-child HIV transmission in another (Burger et al, 1997) .
Whereas causal relationships between low serum retinol among pregnant and lactating HIV infected women, and virus shedding in vaginal secretions and breast milk, and mother-to-child HIV transmission are indeed possible, there could be alternative explanations. It could be due to residual confounding effect of advanced HIV disease. Or, since vitamin A de®ciency often co-exist with other micronutrient de®ciencies, low serum retinol could merely be a marker, and the association due to the confounding effect, of another micronutrient de®ciency affecting progression and transmission. Apparently, no studies exploring the effects of other vitamins or minerals on mother-to-child transmission of HIV have been published.
Four randomised, placebo-controlled, double-blind intervention studies, using vitamin A alone or in combination with one or more vitamins and minerals, are currently ongoing: In Tanzania, the effects of daily supplements with vitamin A (5.000 IU) and four other vitamins are being studied in a two-by-two factorial design. The effect of daily vitamin A supplements (10.000 IU) to pregnant women is being studied in Malawi, and vitamin A (5.000 IU) in combination with b-carotene (30 mg) in South Africa. In Zimbabwe, the effect of daily multi-micronutrient supplementation (vitamin A, 10.000 IU, and 12 other vitamins and minerals in doses corresponding to the US RDA) is currently being studied.
While breast feeding is de®nitely a risk factor for mother-to-child transmission of HIV, this may be a hazardous message to women in developing countries who are rarely aware of their HIV status, and often have no safe alternative to breast feeding. Assuming that the prevalence of HIV in pregnant women is one third, the transmission rate is one third, and that one third of the children becoming HIV infected acquire the infection through breast milk. Then if 100 women avoided breast feeding irrespective of HIV status, then HIV infection would be prevented in 3.7 ((one third) 3 ) children. This has to be compared to the increased morbidity and mortality due to breast feeding deprivation (Victora et al, 1987) in the 67 (two thirds) infants of the uninfected mothers, as well as in the 22 children (1/3 Á 2/3) of HIV infected women that would not have been infected anyway, but also in the 7.4 ((one third) 2 7 (one third) 3 ) infants that had already been infected in utero or intrapartum. Kuhn & Stein (1997) recently modelled the expected frequency of adverse outcomes (HIV infections and infant deaths) associated with different feeding practices, given different mortality rates among breast fed infants of HIV-seronegative women. Not surprisingly, given the known bene®ts of breast feeding, complete avoidance of breast feeding irrespective of HIV status will lead to increased frequency of adverse outcomes, and cessation of breast feeding after three months will lead to increased frequency of adverse outcomes, except in populations with low infant mortality. Nevertheless, the model will further favour breast feeding if the risk of post-natal transmission can be reduced by maternal micronutrient supplementation.
If micronutrient supplementation proves effective against mother-to-child HIV transmission then developing countries may have an affordable public health measure at hand to reduce mother-to-child HIV transmission, that may safely be handed out to all pregnant women irrespective of HIV status. Multiple micronutrients may be added to the iron and folic acid supplements already given to pregnant women in most developing countries at a cost of less than US$1 per pregnancy. Given an HIV prevalence of 20% among pregnant women and a 10% absolute reduction of mother-to-child HIV transmission, the cost per averted case of vertical transmission would be 50$. Most importantly, in contrast to measures limiting breast feeding, micronutrient supplementation may allow maintaining the bene®ts of breast feeding and reducing its risks.
Conclusion
The deleterious effects of HIV infection on micronutrient status, emphasise the importance of possible effects of micronutrient de®ciencies on progression and transmission of HIV. Accumulating suggestive evidence from observational studies points at vitamin A, B 1 , B 2 , B 6 , B 12 , C, E, niacin, and selenium as being most interesting. Nevertheless, the role of some micronutrients, in particular iron and zinc, but also vitamin A and other antioxidants, in HIV infection seem complex, and unfavourable effects of high intakes cannot be precluded.
Some of the methodological dif®culties encountered in observational studies of assessing micronutrient level and intake are overcome in interventional studies. However, intervention studies have problems of their own. The fact that multiple micronutrient de®ciencies usually co-exist and often interact, makes design of interventional studies and interpretation and generalisation of the results dif®cult. For example, zinc is required for mobilisation of vitamin A from the liver stores, wherefore effects of vitamin A supplementation cannot necessarily be generalised to populations with a different zinc intake. Furthermore, as several micronutrients are required for the same immunefunction, repletion of the limiting micronutrient may only increase the function up to a level where another nutrient becomes limiting. Thus, it does not seem reasonable to evaluate a single micronutrient in the context of multiple co-existing and interacting de®ciencies. It may be necessary to use multi-micronutrient supplementation as a study intervention, if feasible using a factorial design.
If improved micronutrient intake proves to reduce progression and transmission of HIV, then early and intensive dietary interventions should be fundamental as part of the case management of HIV infected individuals. However, in developing countries food forti®cation or micronutrient supplementation aiming at increasing micronutrient intake of populations may be feasible and cost-effective public health measures.
